2881 - 2890 of 9156 Results
Title
Year
-
OPENTitle: Conversion of Quinazoline Modulators from Inhibitors to Activators of β-GlucocerebrosidaseJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 62Issue #: 3Start Page: 1218End Page: 1230Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.8b01294Best OA location URL: https://doi.org/10.7270/q280562cCitation Count: 26
- Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPases2016OPENTitle: Phosphoproteomics reveals that Parkinson's disease kinase LRRK2 regulates a subset of Rab GTPasesJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 5Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.7554/elife.12813Best OA location URL: https://doi.org/10.7554/elife.12813Citation Count: 1079
- Multitarget transcranial direct current stimulation for freezing of gait in Parkinson's disease2018RESTRICTEDTitle: Multitarget transcranial direct current stimulation for freezing of gait in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 4Start Page: 642End Page: 646Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27300Best OA location URL: http://doi.org/10.1002/mds.27300Citation Count: 155
-
OPENTitle: (Patho‐)physiological relevance of PINK 1‐dependent ubiquitin phosphorylationJournal Name: The EMBO ReportsPublisher: Springer Science and Business Media LLCVol: 16Issue #: 9Start Page: 1114End Page: 1130Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.15252/embr.201540514Best OA location URL: http://doi.org/10.15252/embr.201540514Citation Count: 189
-
OPENTitle: Dopamine Transporter/α-Synuclein Complexes Are Altered in the Post Mortem Caudate Putamen of Parkinson’s Disease: An In Situ Proximity Ligation Assay StudyJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 19Issue #: 6Start Page: 1611End Page: 1611Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms19061611Best OA location URL: https://www.mdpi.com/1422-0067/19/6/1611/pdf?version=1527671383Citation Count: 28
-
OPENTitle: Adaptive structural changes in the motor cortex and white matter in Parkinson’s diseaseJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 144Issue #: 5Start Page: 861End Page: 879Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00401-022-02488-3Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00401-022-02488-3.pdfCitation Count: 50
- Loss of glutamic acid decarboxylase (Gad67) in striatal neurons expressing the Drdr1a dopamine receptor prevents l-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned mice2015RESTRICTEDTitle: Loss of glutamic acid decarboxylase (Gad67) in striatal neurons expressing the Drdr1a dopamine receptor prevents l-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned miceJournal Name: NeurosciencePublisher: Elsevier BVVol: 303Issue #:Start Page: 586End Page: 594Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuroscience.2015.07.032Citation Count: 19
-
OPENTitle: Intramolecular Povarov Reactions for the Synthesis of Chromenopyridine Fused 2-Pyridone Polyheterocycles Binding to α-Synuclein and Amyloid-β FibrilsJournal Name: The Journal of Organic ChemistryPublisher: American Chemical Society (ACS)Vol: 85Issue #: 21Start Page: 14174End Page: 14189Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acs.joc.0c01699Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acs.joc.0c01699Citation Count: 23
-
OPENTitle: Quantitative measures of total and phosphorylated alpha-synuclein in skin tissue as potential biomarkers for synucleinopathiesJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 16Issue #: 3Start Page: 438End Page: 451Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1177/1877718x261420669Best OA location URL: https://doi.org/10.1177/1877718x261420669Citation Count: 0
-
OPENTitle: Pimavanserin versus quetiapine for the treatment of psychosis in Parkinson's disease and dementia with Lewy bodiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 69Issue #:Start Page: 119End Page: 124Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.11.009Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7061324Citation Count: 41